MUC1 and lung carcinoma: KL-6 is produced by the shedding of the extracellular domain of MUCIN 1, a glycoprotein mainly expressed by damaged alveolar type II cells and has been shown to have an anti-inflammatory action through the inhibition of Toll-like receptor signaling but also participates in lung cancer progression and development of fibrotic processes [6].